Kura Oncology (KURA) Notes Payables (2010 - 2015)
Kura Oncology's (KURA) quarterly Notes Payables came in at $232000.0 in Q4 2015, down 88.61% year-on-year from $2.0 million in Q4 2014, and little changed on a QoQ basis from $232000.0 in Q3 2015.
Kura Oncology (KURA) Notes Payables (2010 - 2015) Analysis & Trends
Kura Oncology (KURA) has 6 years of Notes Payables data on file, last reported at $232000.0 in Q4 2015.
- On a quarterly basis, Notes Payables fell 88.61% year-over-year to $232000.0 in Q4 2015; TTM through Dec 2015 was $232000.0, a 88.61% decrease from a year earlier, with the FY2015 full-year figure at $232000.0, down 88.61% from the prior year.
- Notes Payables for Q4 2015 stood at $232000.0, roughly flat from $232000.0 in the prior quarter.
- Over the last five years, Notes Payables for KURA reached as high as $2.0 million in Q4 2014 and fell as low as $60000.0 in Q1 2011.
- Historically, Notes Payables has averaged $258000.0 across 5 years, with a median of $110000.0 in 2013.
- Across the five-year window, Notes Payables soared 1750.91% in 2014 and tumbled 88.61% in 2015, its largest moves.
- Year by year, Notes Payables stood at $60000.0 in 2011, then jumped by 41.67% to $85000.0 in 2012, then rose by 29.41% to $110000.0 in 2013, then surged by 1750.91% to $2.0 million in 2014, then tumbled by 88.61% to $232000.0 in 2015.
- Per Business Quant data, the three most recent Notes Payables figures were $232000.0 in Q4 2015, $232000.0 in Q3 2015, and $1.1 million in Q1 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Kura Oncology | 925.97 Mn | 925.97 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 232,000.00 |
| Sep 30, 2015 | 232,000.00 |
| Mar 31, 2015 | 1.06 Mn |
| Dec 31, 2014 | 2.04 Mn |
| Sep 30, 2014 | 125,000.00 |
| Jun 30, 2014 | 110,000.00 |
| Mar 31, 2014 | 110,000.00 |
| Dec 31, 2013 | 110,000.00 |
| Sep 30, 2013 | 110,000.00 |
| Jun 30, 2013 | 110,000.00 |
| Mar 31, 2013 | 85,000.00 |
| Dec 31, 2012 | 85,000.00 |
| Sep 30, 2012 | 85,000.00 |
| Jun 30, 2012 | 85,000.00 |
| Mar 31, 2012 | 85,000.00 |
| Dec 31, 2011 | 60,000.00 |
| Sep 30, 2011 | 60,000.00 |
| Jun 30, 2011 | 60,000.00 |
| Mar 31, 2011 | 60,000.00 |
| Dec 31, 2010 | 60,000.00 |